Phase II single arm data of frontline Ibrutinib and venetoclax in older or high risk patients with CLL. Patients had either del(17p), TP53-mutated, del(11q), unmutated IgVH, or age 65 years or older. 75% of patients achieved marrow uMRD as best response. Estimated 3 year PFS was 93%.
ILAE 的网站上多数的内容是英文的, 但也有些文件有其他语言的版本. 我们在这个网页上提供了所有具有中文版的文件和资源. 如果你知道一些可能令癫痫社区感兴趣的中文资源的话, 请联络 Contact ILAE 癫痫实用临床定义 – A practical clinical definition of epilepsy, Epilepsia (2014) 癫痫术语和概念的修订 – Revised terminology and concepts for…
The outgoing RCPCH president is “ashamed” of the state of child health in the UK, she tells Gareth Iacobucci . But there are quick wins…
Care workers accused of abuse are able to escape investigation due to a national loophole, warns senior social worker
Mixotrophs, which have characteristics of both animals and plants, could help blunt the effects of marine heat waves on ocean ecosystems
Telia Company AB was the leading telecommunication company within the Nordic countries by turnover, as of April 2024.
This Medical News story examines other potential uses of GLP-1 receptor agonists, the popular type 2 diabetes and weight-loss drugs.
To be able to register, an individual MyEAN account for each participant is required. The same login data is used to gain access to the…
Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon, summarizes a talk on the current standard of care, outcomes, and unmet…
